Glaxo pays record $3bn in tax row
261103
Drugs giant GlaxoSmithKline agrees to pay out a record $3.1bn to end a tax row with the US government.
315747
GlaxoSmithKline Plc GSK.L has agreed  to release all clinical studies of its drugs to settle a  lawsuit that accused it of withholding negative information  about the antidepressant Paxil, the New York Attorney General's  office said on Thursday.
203734
GlaxoSmithKline Plc  has signed a  drug discovery deal with U.S. biotech firm ChemoCentryx  potentially worth up to $1.5 billion in milestone payments and  research funding to the privately owned group.
28046
More than $31bn (Â£16bn) was yesterday knocked off the value of Pfizer, the world&#39;s largest pharmaceutical company and maker of Viagra, after doubts surfaced over the safety of one of its key drugs.
69626
British drug maker GlaxoSmithKline said Wednesday it was giving up a Chinese patent for a component of its popular diabetes drug Avandia following a challenge by three Chinese competitors.
737619
The president of U.S. pharmaceuticals at GlaxoSmithKline Plc , Chris Viehbacher, said on Wednesday it was too early to write off the diabetes drug Avandia, which he said could once again return to annual sales of more than $3 billion.
18700
HMRC figures it out Missing trader or carousel fraud cost Her Majesty's Revenue and Customs Â£3bn in the last financial year.â¦
77441
AstraZeneca, Bristol-Myers Squibb and Schering-Plough must pay damages for overcharging on certain drugs.
170831
GlaxoSmithKline Plc  has bought  global rights to Danish biotech company Genmab's  most  promising new drug, a treatment for leukemia, in a record deal  worth up to $2.1 billion, the two firms said on Tuesday.
18221
Genzyme has agreed to pay at least $325 million to win the hotly contested rights to a potentially powerful cholesterol-lowering drug.
343050
The drugmaker posted third-quarter net income of $1.53 billion as revenues increased by double digits, while lower costs offset more spending on research and development.
398785
A leaked, confidential journal article could get Glaxo in hot water.
211417
GlaxoSmithKline PLC reported a 5.8 percent drop in third-quarter net profit Wednesday on strong generic competition and falling sales of its blockbuster diabetes drug in the United States.
477715
Pharmaceutical group GlaxoSmithKline (GSK) has agreed to buy antibody therapy developer Domantis for 230 million pounds.
272085
British drug maker Glaxo sees increased generic competition for its anti-depressant drugs.
265537
British drugmaker GlaxoSmithKline PLC reported a 9 percent drop in third-quarter earnings Thursday, citing stiff competition from generic drug makers.
335251
Pharmaceutical company GlaxoSmithKline PLC said Monday that Bayer Healthcare AG has paid more than 200 million euros (&#36;260 million) for sole marketing rights outside the United States for the erectile dysfunction drug Levitra.